MTOR and colorectal cancer: demonstrated the significant impact of BEZ-235, when co-administered with Osimerin (an NF-κB inhibitor), in inhibiting the PI3K/Akt/mTOR/NF-κB axis, inducing apoptosis in HCT-116 colorectal cancer cells (38).